Abstract
As defined by the World Health Organization (WHO), palliative care aims to improve quality of life in patients suffering from life-threatening disease. When dealing with intolerable and treatment-refractory symptoms, palliative sedation (PS) is an option of last resort. The European Association for Palliative Care (EAPC) defines PS as the monitored use of medications intended to induce a state of decreased or absent awareness in order to relieve the burden of otherwise intractable suffering in an ethically acceptable manner (Cherny N, Radbruch L. Palliative Medicine 2009; 23: 581–593). Although PS has gained increasing research interest and is widely accepted as important and necessary therapy in palliative medicine, guidelines exist only for adults (Kirk T, Mahon M. J Pain Symptom Manage 2010; 39: 914–923).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
